Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Blood Pressure Variability and Cardiovascular Outcomes in Patients With Prior Stroke: A Secondary Analysis of PRoFESS.

de Havenon A, Fino NF, Johnson B, Wong KH, Majersik JJ, Tirschwell D, Rost N.

Stroke. 2019 Sep 20:STROKEAHA119026293. doi: 10.1161/STROKEAHA.119.026293. [Epub ahead of print]

PMID:
31537194
2.

Effect of Time Elapsed since Gadolinium Administration on Atherosclerotic Plaque Enhancement in Clinical Vessel Wall MR Imaging Studies.

de Havenon A, Muhina HJ, Parker DL, McNally JS, Alexander MD.

AJNR Am J Neuroradiol. 2019 Sep 12. doi: 10.3174/ajnr.A6191. [Epub ahead of print]

PMID:
31515211
3.

Is There Equipoise Regarding the Optimal Medical Treatment of Patients with Asymptomatic White Matter Hyperintensities?

de Havenon A, Prabhakaran S, Turan T, Gottesman R, Yeatts S, Rost N.

J Stroke Cerebrovasc Dis. 2019 Sep 5:104371. doi: 10.1016/j.jstrokecerebrovasdis.2019.104371. [Epub ahead of print]

PMID:
31495669
4.

Peri-procedural stroke or death in stenting of symptomatic severe intracranial stenosis.

Yaghi S, Khatri P, de Havenon A, Yeatts S, Chang AD, Cutting S, Mac Grory B, Burton T, Jayaraman MV, McTaggart RA, Fiorella D, Derdeyn C, Zaidat S, Dehkharghani S, Amin-Hanjani S, Furie K, Prahbakaran S, Liebeskind D.

J Neurointerv Surg. 2019 Sep 4. pii: neurintsurg-2019-015225. doi: 10.1136/neurintsurg-2019-015225. [Epub ahead of print]

PMID:
31484697
5.

Subclinical Cerebrovascular Disease: Epidemiology and Treatment.

de Havenon A, Meyer C, McNally JS, Alexander M, Chung L.

Curr Atheroscler Rep. 2019 Jul 27;21(10):39. doi: 10.1007/s11883-019-0799-1. Review.

PMID:
31350593
6.

Carotid Artery Stiffness Accurately Predicts White Matter Hyperintensity Volume 20 Years Later: A Secondary Analysis of the Atherosclerosis Risk in the Community Study.

de Havenon A, Wong KH, Elkhetali A, McNally JS, Majersik JJ, Rost NS.

AJNR Am J Neuroradiol. 2019 Aug;40(8):1369-1373. doi: 10.3174/ajnr.A6115. Epub 2019 Jun 27.

PMID:
31248859
7.

Increased blood pressure variability after acute ischemic stroke increases the risk of death: A secondary analysis of the Virtual International Stroke Trial Archive.

de Havenon A, Stoddard G, Saini M, Wong KH, Tirschwell D, Bath P; VISTA-Acute Collaborators.

JRSM Cardiovasc Dis. 2019 Jun 11;8:2048004019856496. doi: 10.1177/2048004019856496. eCollection 2019 Jan-Dec.

8.

Diurnal Variations in the First 24/7 Mobile Stroke Unit.

Zaidat OO, Changal KH, Sultan-Qurraie A, de Havenon A, Calderon VJ, Goins-Whitmore J, Patterson MS, Lin E.

Stroke. 2019 Jul;50(7):1911-1914. doi: 10.1161/STROKEAHA.119.024950. Epub 2019 May 20.

PMID:
31104620
9.

Response by de Havenon et al to Letter Regarding Article, "Results From DEFUSE 3: Good Collaterals Are Associated With Reduced Ischemic Core Growth but Not Neurologic Outcome".

de Havenon A, Albers GW, Heit JJ.

Stroke. 2019 Jun;50(6):e166. doi: 10.1161/STROKEAHA.119.025713. Epub 2019 May 14. No abstract available.

PMID:
31084323
10.

Mental illness, implicit attitudes, and disparity of carotid revascularization after stroke.

Kalra L, de Havenon A.

Neurology. 2019 May 28;92(22):1033-1034. doi: 10.1212/WNL.0000000000007563. Epub 2019 May 3. No abstract available.

PMID:
31053661
11.

Blood pressure, glycemic control, and white matter hyperintensity progression in type 2 diabetics.

de Havenon A, Majersik JJ, Tirschwell DL, McNally JS, Stoddard G, Rost NS.

Neurology. 2019 Mar 12;92(11):e1168-e1175. doi: 10.1212/WNL.0000000000007093. Epub 2019 Feb 8.

PMID:
30737332
12.

Results From DEFUSE 3: Good Collaterals Are Associated With Reduced Ischemic Core Growth but Not Neurologic Outcome

de Havenon A, Mlynash M, Kim-Tenser MA, Lansberg MG, Leslie-Mazwi T, Christensen S, McTaggart RA, Alexander M, Albers G, Broderick J, Marks MP, Heit JJ; DEFUSE 3 Investigators.

Stroke. 2019 Mar;50(3):632-638. doi: 10.1161/STROKEAHA.118.023407.

PMID:
30726184
13.

Assessment of quantitative methods for enhancement measurement on vessel wall magnetic resonance imaging evaluation of intracranial atherosclerosis.

Alexander MD, de Havenon A, Kim SE, Parker DL, McNally JS.

Neuroradiology. 2019 Jun;61(6):643-650. doi: 10.1007/s00234-019-02167-3. Epub 2019 Jan 24.

PMID:
30675639
14.

SEIMLESS: Simultaneous Extracranial, Intracranial Management of (tandem) LESsions in Stroke.

Sultan-Qurraie A, Witt T, de Havenon A, Ribo M, Zaidat OO.

J Neurointerv Surg. 2019 Sep;11(9):879-883. doi: 10.1136/neurintsurg-2018-014403. Epub 2019 Jan 23.

PMID:
30674634
15.

Magnetic Resonance Imaging and Clinical Factors Associated With Ischemic Stroke in Patients Suspected of Cervical Artery Dissection.

McNally JS, Hinckley PJ, Sakata A, Eisenmenger LB, Kim SE, De Havenon AH, Quigley EP, Iacob E, Treiman GS, Parker DL.

Stroke. 2018 Oct;49(10):2337-2344. doi: 10.1161/STROKEAHA.118.021868.

PMID:
30355108
16.

Increased Blood Pressure Variability Contributes to Worse Outcome After Intracerebral Hemorrhage.

de Havenon A, Majersik JJ, Stoddard G, Wong KH, McNally JS, Smith AG, Rost NS, Tirschwell DL.

Stroke. 2018 Aug;49(8):1981-1984. doi: 10.1161/STROKEAHA.118.022133.

17.

Low b-value diffusion weighted imaging is promising in the diagnosis of brain death and hypoxic-ischemic injury secondary to cardiopulmonary arrest.

Peckham ME, Anderson JS, Rassner UA, Shah LM, Hinckley PJ, de Havenon A, Kim SE, McNally JS.

Crit Care. 2018 Jun 20;22(1):165. doi: 10.1186/s13054-018-2087-9.

18.

Increased blood pressure variability after endovascular thrombectomy for acute stroke is associated with worse clinical outcome.

Bennett AE, Wilder MJ, McNally JS, Wold JJ, Stoddard GJ, Majersik JJ, Ansari S, de Havenon A.

J Neurointerv Surg. 2018 Sep;10(9):823-827. doi: 10.1136/neurintsurg-2017-013473. Epub 2018 Jan 19.

PMID:
29352059
19.

In large vessel occlusive stroke, time is brain… but collaterals are time.

de Havenon A, Southerland AM.

Neurology. 2018 Jan 23;90(4):153-154. doi: 10.1212/WNL.0000000000004870. Epub 2017 Dec 27. No abstract available.

PMID:
29282331
20.

Added Value of Vessel Wall Magnetic Resonance Imaging for Differentiation of Nonocclusive Intracranial Vasculopathies.

Mossa-Basha M, Shibata DK, Hallam DK, de Havenon A, Hippe DS, Becker KJ, Tirschwell DL, Hatsukami T, Balu N, Yuan C.

Stroke. 2017 Nov;48(11):3026-3033. doi: 10.1161/STROKEAHA.117.018227. Epub 2017 Oct 13.

21.

Validation of the unruptured intracranial aneurysm treatment score: comparison with real-world cerebrovascular practice.

Ravindra VM, de Havenon A, Gooldy TC, Scoville J, Guan J, Couldwell WT, Taussky P, MacDonald JD, Schmidt RH, Park MS.

J Neurosurg. 2018 Jul;129(1):100-106. doi: 10.3171/2017.4.JNS17548. Epub 2017 Oct 6.

PMID:
28984518
22.

Determinants of the impact of blood pressure variability on neurological outcome after acute ischaemic stroke.

de Havenon A, Bennett A, Stoddard GJ, Smith G, Chung L, O'Donnell S, McNally JS, Tirschwell D, Majersik JJ.

Stroke Vasc Neurol. 2017 Feb 24;2(1):1-6. doi: 10.1136/svn-2016-000057. eCollection 2017 Mar.

23.

High-resolution vessel wall MRI for the evaluation of intracranial atherosclerotic disease.

de Havenon A, Mossa-Basha M, Shah L, Kim SE, Park M, Parker D, McNally JS.

Neuroradiology. 2017 Dec;59(12):1193-1202. doi: 10.1007/s00234-017-1925-9. Epub 2017 Sep 23. Review.

PMID:
28942481
24.

Carotid intraplaque hemorrhage on vessel wall MRI does not correlate with TCD emboli monitoring in patients with recently symptomatic carotid atherosclerosis.

de Havenon A, Tirschwell D, Majersik JJ, McNally S, Stoddard G, Moore A, Mossa-Basha M.

Neuroradiol J. 2017 Oct;30(5):486-489. doi: 10.1177/1971400917707351. Epub 2017 Jun 20.

25.

Magnetic Resonance Imaging Detection of Intraplaque Hemorrhage.

McNally JS, Kim SE, Mendes J, Hadley JR, Sakata A, De Havenon AH, Treiman GS, Parker DL.

Magn Reson Insights. 2017 Mar 7;10:1-8. doi: 10.1177/1178623X17694150. eCollection 2017. Review.

26.

Advanced imaging in acute ischemic stroke.

Kilburg C, Scott McNally J, de Havenon A, Taussky P, Kalani MY, Park MS.

Neurosurg Focus. 2017 Apr;42(4):E10. doi: 10.3171/2017.1.FOCUS16503. Review.

PMID:
28366054
27.

Association of Collateral Blood Vessels Detected by Arterial Spin Labeling Magnetic Resonance Imaging With Neurological Outcome After Ischemic Stroke.

de Havenon A, Haynor DR, Tirschwell DL, Majersik JJ, Smith G, Cohen W, Andre JB.

JAMA Neurol. 2017 Apr 1;74(4):453-458. doi: 10.1001/jamaneurol.2016.4491.

28.

Increased Blood Pressure Variability Is Associated with Worse Neurologic Outcome in Acute Anterior Circulation Ischemic Stroke.

de Havenon A, Bennett A, Stoddard GJ, Smith G, Wang H, Wold J, Chung L, Tirschwell DL, Majersik JJ.

Stroke Res Treat. 2016;2016:7670161. Epub 2016 Nov 15.

29.

Response to "High-Resolution Vessel Wall MRI: Appearance of Intravascular Lymphoma Mimics Central Nervous System Vasculitis".

de Havenon A, McNally S.

Clin Neuroradiol. 2016 Dec;26(4):501. Epub 2016 Nov 7. No abstract available.

PMID:
27822627
30.

Treatment of Carotid Intramural Thrombus With TPA.

Bennett A, Wold J, de Havenon A.

JAMA Neurol. 2016 Dec 1;73(12):1496. doi: 10.1001/jamaneurol.2016.3223. No abstract available.

PMID:
27802501
31.

Rare case of T-cell lymphoma presenting as acute myelopathy.

Samara VC, de Havenon A.

BMJ Case Rep. 2016 Oct 21;2016. pii: bcr2016217944. doi: 10.1136/bcr-2016-217944.

32.

Vessel wall MRI of an inflamed aneurysm with atherosclerosis in a patient with ischemic stroke.

de Havenon A, Park M, McNally S.

Neurology. 2016 Aug 16;87(7):741-2. doi: 10.1212/WNL.0000000000002990. No abstract available.

33.

Added Value of Vessel Wall Magnetic Resonance Imaging in the Differentiation of Moyamoya Vasculopathies in a Non-Asian Cohort.

Mossa-Basha M, de Havenon A, Becker KJ, Hallam DK, Levitt MR, Cohen WA, Hippe DS, Alexander MD, Tirschwell DL, Hatsukami T, Amlie-Lefond C, Yuan C.

Stroke. 2016 Jul;47(7):1782-8. doi: 10.1161/STROKEAHA.116.013320. Epub 2016 Jun 7.

34.

Prediction of Carotid Intraplaque Hemorrhage Using Adventitial Calcification and Plaque Thickness on CTA.

Eisenmenger LB, Aldred BW, Kim SE, Stoddard GJ, de Havenon A, Treiman GS, Parker DL, McNally JS.

AJNR Am J Neuroradiol. 2016 Aug;37(8):1496-503. doi: 10.3174/ajnr.A4765. Epub 2016 Apr 21.

35.

Tissue Plasminogen Activator Prescription and Administration Errors within a Regional Stroke System.

Chung LS, Tkach A, Lingenfelter EM, Dehoney SB, Rollo J, de Havenon A, DeWitt LD, Grantz MR, Wang H, Wold JJ, Hannon PM, Weathered NR, Majersik JJ.

J Stroke Cerebrovasc Dis. 2016 Mar;25(3):565-71. doi: 10.1016/j.jstrokecerebrovasdis.2015.11.014. Epub 2015 Dec 11.

36.

Nonstenotic Culprit Plaque: The Utility of High-Resolution Vessel Wall MRI of Intracranial Vessels after Ischemic Stroke.

de Havenon A, Yuan C, Tirschwell D, Hatsukami T, Anzai Y, Becker K, Sultan-Qurraie A, Mossa-Basha M.

Case Rep Radiol. 2015;2015:356582. doi: 10.1155/2015/356582. Epub 2015 Aug 6.

37.

Medial Occipital Lobe Hyperperfusion Identified by Arterial Spin-Labeling: A Poor Prognostic Sign in Patients with Hypoxic-Ischemic Encephalopathy.

de Havenon A, Sultan-Qurraie A, Tirschwell D, Cohen W, Majersik J, Andre JB.

AJNR Am J Neuroradiol. 2015 Dec;36(12):2292-5. doi: 10.3174/ajnr.A4444. Epub 2015 Sep 3.

38.

Ischemic stroke patients with active malignancy or extracardiac shunts are more likely to have a right-to-left shunt found by TCD than echocardiogram.

de Havenon A, Moore A, Sultan-Qurraie A, Majersik JJ, Stoddard G, Tirschwell D.

Transl Stroke Res. 2015 Oct;6(5):361-4. doi: 10.1007/s12975-015-0414-x. Epub 2015 Jul 25.

PMID:
26205844
39.

A pilot study of audiovisual family meetings in the intensive care unit.

de Havenon A, Petersen C, Tanana M, Wold J, Hoesch R.

J Crit Care. 2015 Oct;30(5):881-3. doi: 10.1016/j.jcrc.2015.05.027. Epub 2015 Jun 3.

PMID:
26100581
40.

Multicontrast high-resolution vessel wall magnetic resonance imaging and its value in differentiating intracranial vasculopathic processes.

Mossa-Basha M, Hwang WD, De Havenon A, Hippe D, Balu N, Becker KJ, Tirschwell DT, Hatsukami T, Anzai Y, Yuan C.

Stroke. 2015 Jun;46(6):1567-73. doi: 10.1161/STROKEAHA.115.009037. Epub 2015 May 7.

PMID:
25953365
41.

Development of regional stroke programs.

de Havenon A, Sultan-Qurraie A, Hannon P, Tirschwell D.

Curr Neurol Neurosci Rep. 2015 May;15(5):544. doi: 10.1007/s11910-015-0544-2. Review.

PMID:
25763758
42.

Posterior reversible encephalopathy syndrome with spinal cord involvement.

de Havenon A, Joos Z, Longenecker L, Shah L, Ansari S, Digre K.

Neurology. 2014 Nov 25;83(22):2002-6. doi: 10.1212/WNL.0000000000001026. Epub 2014 Oct 29.

PMID:
25355822
43.

Extensive cortical diffusion restriction in a 50-year-old female with hyperammonemic encephalopathy and status epilepticus.

de Havenon A, French K, Ansari S.

Case Rep Neurol Med. 2014;2014:257094. doi: 10.1155/2014/257094. Epub 2014 Apr 24.

44.

Splenic rupture associated with primary CMV infection, AMSAN, and IVIG.

de Havenon A, Davis G, Hoesch R.

J Neuroimmunol. 2014 Jul 15;272(1-2):103-5. doi: 10.1016/j.jneuroim.2014.05.004. Epub 2014 May 10.

PMID:
24856574
45.

Chiari I Malformation Causing Developmental Regression in a 4 Month Old.

Doll ES, Bonkowsky JL, Brown LL, de Havenon AH, Brockmeyer DL, Glasgow TS, Morita DC.

Glob Pediatr Health. 2014 Nov 21;1:2333794X14560819. doi: 10.1177/2333794X14560819. eCollection 2014. No abstract available.

46.

A perforated diverticulum in Cushing's disease.

de Havenon A, Ehrenkranz J.

Int J Surg Case Rep. 2011;2(7):215-7. doi: 10.1016/j.ijscr.2011.06.009. Epub 2011 Jul 22.

47.

The secret "spice": an undetectable toxic cause of seizure.

de Havenon A, Chin B, Thomas KC, Afra P.

Neurohospitalist. 2011 Oct;1(4):182-6. doi: 10.1177/1941874411417977.

Supplemental Content

Loading ...
Support Center